THF-gamma 2 modified peptide (Intitute of Materia Medica)

N/A

Report date: 2025/03/20 10:04:53

Base Information

Drug NameTHF-gamma 2 modified peptide (Intitute of Materia Medica)
Drug Alias Namesaimoruilin
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsImmune System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Medicinal Of Biotechnology Chinese Academy Of Medical Sciences
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medicinal Of Biotechnology Chinese Academy Of Medical Sciences
Inactive CompaniesN/A
Active IndicationsImmune System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A